Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

A versatile RNA vector for delivery of coding and noncoding RNAs.

Schmid S, Zony LC, tenOever BR.

J Virol. 2014 Feb;88(4):2333-6. doi: 10.1128/JVI.03267-13. Epub 2013 Dec 4.

2.

Use of herpes simplex virus type 1-based amplicon vector for delivery of small interfering RNA.

Sabbioni S, Callegari E, Manservigi M, Argnani R, Corallini A, Negrini M, Manservigi R.

Gene Ther. 2007 Mar;14(5):459-64. Epub 2006 Oct 19.

PMID:
17051250
3.

Cytoplasmic RNA viruses as potential vehicles for the delivery of therapeutic small RNAs.

Usme-Ciro JA, Campillo-Pedroza N, Almazán F, Gallego-Gomez JC.

Virol J. 2013 Jun 7;10:185. doi: 10.1186/1743-422X-10-185. Review.

4.

Genetic engineering of animal RNA viruses.

Conzelmann KK, Meyers G.

Trends Microbiol. 1996 Oct;4(10):386-93. Review.

PMID:
8899964
5.

Genetic engineering of influenza and other negative-strand RNA viruses containing segmented genomes.

Neumann G, Kawaoka Y.

Adv Virus Res. 1999;53:265-300. Review. No abstract available.

PMID:
10582103
6.

Negative-strand RNA viruses: applications to biotechnology.

García-Sastre A.

Trends Biotechnol. 1998 May;16(5):230-5. Review.

PMID:
9621463
7.

Gene silencing--principles and application.

Horser C, Abbott D, Wesley V, Smith N, Waterhouse P.

Genet Eng (N Y). 2002;24:239-56. Review. No abstract available.

PMID:
12416308
8.

Generation of a safe and effective live viral vaccine by virus self-attenuation using species-specific artificial microRNA.

Li J, Arévalo MT, Diaz-Arévalo D, Chen Y, Choi JG, Zeng M.

J Control Release. 2015 Jun 10;207:70-6. doi: 10.1016/j.jconrel.2015.04.001. Epub 2015 Apr 7.

9.

No false start for novel pseudotyped vectors.

Sanders DA.

Curr Opin Biotechnol. 2002 Oct;13(5):437-42. Review.

PMID:
12459334
10.

Evidence for a crucial role of a host non-coding RNA in influenza A virus replication.

Winterling C, Koch M, Koeppel M, Garcia-Alcalde F, Karlas A, Meyer TF.

RNA Biol. 2014;11(1):66-75. doi: 10.4161/rna.27504. Epub 2013 Dec 20.

11.

Optimization of baculovirus transduction on FreeStyle293 cells for the generation of influenza B/Lee/40.

Nakowitsch S, Kittel C, Ernst W, Egorov A, Grabherr R.

Mol Biotechnol. 2006 Oct;34(2):157-64.

PMID:
17172661
12.
13.

Simian immunodeficiency virus vector pseudotypes differ in transduction efficiency and target cell specificity in brain.

Liehl B, Hlavaty J, Moldzio R, Tonar Z, Unger H, Salmons B, Günzburg WH, Renner M.

Gene Ther. 2007 Sep;14(18):1330-43. Epub 2007 Jul 5.

PMID:
17611586
14.

Accessibility of the coxsackievirus and adenovirus receptor and its importance in adenovirus gene transduction efficiency.

Sharma P, Kolawole AO, Wiltshire SM, Frondorf K, Excoffon KJ.

J Gen Virol. 2012 Jan;93(Pt 1):155-8. doi: 10.1099/vir.0.036269-0. Epub 2011 Sep 14.

15.

Alphavirus transducing system: tools for visualizing infection in mosquito vectors.

Phillips A, Mossel E, Sanchez-Vargas I, Foy B, Olson K.

J Vis Exp. 2010 Nov 24;(45). pii: 2363. doi: 10.3791/2363.

16.

Adenovirus vector-mediated doxycycline-inducible RNA interference.

Hosono T, Mizuguchi H, Katayama K, Xu ZL, Sakurai F, Ishii-Watabe A, Kawabata K, Yamaguchi T, Nakagawa S, Mayumi T, Hayakawa T.

Hum Gene Ther. 2004 Aug;15(8):813-9.

PMID:
15319038
17.
18.

SIV Vectors.

Ruggieri A, Nègre D, Cosset FL.

Methods Mol Biol. 2003;229:233-49. No abstract available.

PMID:
12824635
19.

Lentiviral-mediated delivery of siRNAs for antiviral therapy.

Morris KV, Rossi JJ.

Gene Ther. 2006 Mar;13(6):553-8. Review.

PMID:
16397511
20.

Supplemental Content

Support Center